Stryker Cost of Goods Sold 2010-2024 | SYK
Stryker annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Stryker cost of goods sold for the quarter ending June 30, 2024 was $2.006B, a 10.52% increase year-over-year.
- Stryker cost of goods sold for the twelve months ending June 30, 2024 was $7.779B, a 7.44% increase year-over-year.
- Stryker annual cost of goods sold for 2023 was $7.44B, a 8.28% increase from 2022.
- Stryker annual cost of goods sold for 2022 was $6.871B, a 11.91% increase from 2021.
- Stryker annual cost of goods sold for 2021 was $6.14B, a 15.98% increase from 2020.
| Stryker Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $7,440 |
| 2022 | $6,871 |
| 2021 | $6,140 |
| 2020 | $5,294 |
| 2019 | $5,188 |
| 2018 | $4,663 |
| 2017 | $4,264 |
| 2016 | $3,821 |
| 2015 | $3,344 |
| 2014 | $3,319 |
| 2013 | $3,002 |
| 2012 | $2,781 |
| 2011 | $2,811 |
| 2010 | $2,286 |
| 2009 | $2,184 |
| Stryker Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-06-30 | $2,006 |
| 2024-03-31 | $1,910 |
| 2023-12-31 | $2,112 |
| 2023-09-30 | $1,751 |
| 2023-06-30 | $1,815 |
| 2023-03-31 | $1,762 |
| 2022-12-31 | $1,966 |
| 2022-09-30 | $1,697 |
| 2022-06-30 | $1,667 |
| 2022-03-31 | $1,541 |
| 2021-12-31 | $1,656 |
| 2021-09-30 | $1,518 |
| 2021-06-30 | $1,522 |
| 2021-03-31 | $1,444 |
| 2020-12-31 | $1,545 |
| 2020-09-30 | $1,276 |
| 2020-06-30 | $1,216 |
| 2020-03-31 | $1,257 |
| 2019-12-31 | $1,428 |
| 2019-09-30 | $1,257 |
| 2019-06-30 | $1,270 |
| 2019-03-31 | $1,233 |
| 2018-12-31 | $1,340 |
| 2018-09-30 | $1,087 |
| 2018-06-30 | $1,132 |
| 2018-03-31 | $1,104 |
| 2017-12-31 | $1,230 |
| 2017-09-30 | $1,022 |
| 2017-06-30 | $1,021 |
| 2017-03-31 | $991 |
| 2016-12-31 | $1,062 |
| 2016-09-30 | $960 |
| 2016-06-30 | $998 |
| 2016-03-31 | $801 |
| 2015-12-31 | $895 |
| 2015-09-30 | $796 |
| 2015-06-30 | $827 |
| 2015-03-31 | $826 |
| 2014-12-31 | $899 |
| 2014-09-30 | $829 |
| 2014-06-30 | $815 |
| 2014-03-31 | $776 |
| 2013-12-31 | $877 |
| 2013-09-30 | $682 |
| 2013-06-30 | $730 |
| 2013-03-31 | $713 |
| 2012-12-31 | $745 |
| 2012-09-30 | $655 |
| 2012-06-30 | $672 |
| 2012-03-31 | $709 |
| 2011-12-31 | $740 |
| 2011-09-30 | $669 |
| 2011-06-30 | $713 |
| 2011-03-31 | $689 |
| 2010-12-31 | $624 |
| 2010-09-30 | $541 |
| 2010-06-30 | $539 |
| 2010-03-31 | $581 |
| 2009-12-31 | $594 |
| 2009-09-30 | $539 |
| 2009-06-30 | $536 |
| 2009-03-31 | $516 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $137.705B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $199.879B | 25.82 |
| Boston Scientific (BSX) | United States | $121.595B | 37.03 |
| Medtronic (MDT) | Ireland | $113.026B | 16.82 |
| EssilorLuxottica (ESLOY) | France | $104.378B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.118B | 35.17 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.437B | 0.00 |
| ResMed (RMD) | United States | $34.974B | 30.79 |
| Koninklijke Philips (PHG) | Netherlands | $29.016B | 22.05 |
| Terumo (TRUMY) | Japan | $27.876B | 39.37 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.644B | 13.63 |
| Baxter (BAX) | United States | $20.086B | 13.62 |
| Insulet (PODD) | United States | $16.555B | 69.65 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.426B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.489B | 31.44 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.672B | 32.44 |
| Lantheus Holdings (LNTH) | United States | $7.508B | 18.02 |
| ICU Medical (ICUI) | United States | $4.304B | 41.08 |
| TG Therapeutics (TGTX) | United States | $3.909B | 41.39 |
| Haemonetics (HAE) | United States | $3.870B | 19.14 |
| Perrigo (PRGO) | Ireland | $3.841B | 12.14 |
| GN Store Nord (GNNDY) | Denmark | $3.758B | 22.64 |
| Neogen (NEOG) | United States | $3.736B | 39.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.644B | 18.16 |
| Envista Holdings (NVST) | United States | $3.298B | 17.60 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.591B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.311B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.171B | 36.43 |
| LeMaitre Vascular (LMAT) | United States | $1.996B | 53.20 |
| AdaptHealth (AHCO) | United States | $1.524B | 11.00 |
| InMode (INMD) | Israel | $1.466B | 9.34 |
| Warby Parker (WRBY) | United States | $1.466B | 0.00 |
| AtriCure (ATRC) | United States | $1.363B | 0.00 |
| Owens & Minor (OMI) | United States | $1.219B | 9.41 |
| Verano Holdings (VRNOF) | United States | $1.114B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.094B | 0.00 |
| Evolus (EOLS) | United States | $1.023B | 0.00 |
| PetIQ (PETQ) | United States | $0.920B | 23.32 |
| Phibro Animal Health (PAHC) | United States | $0.897B | 18.61 |
| National Vision Holdings (EYE) | United States | $0.864B | 27.48 |
| Cresco Labs (CRLBF) | United States | $0.801B | 0.00 |
| Surmodics (SRDX) | United States | $0.561B | 119.09 |
| Quanterix (QTRX) | United States | $0.543B | 0.00 |
| ZimVie (ZIMV) | United States | $0.454B | 42.23 |
| VAREX IMAGING (VREX) | United States | $0.451B | 13.62 |
| Valneva SE (VALN) | France | $0.422B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.406B | 0.00 |
| Jin Medical (ZJYL) | China | $0.397B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.333B | 0.00 |
| Cerus (CERS) | United States | $0.330B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.321B | 8.29 |
| Aurora Cannabis (ACB) | Canada | $0.320B | 0.00 |
| Biote (BTMD) | United States | $0.319B | 14.70 |
| Viemed Healthcare (VMD) | United States | $0.287B | 30.79 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| Zynex (ZYXI) | United States | $0.260B | 45.44 |
| Utah Medical Products (UTMD) | United States | $0.234B | 15.52 |
| Ayr Wellness (AYRWF) | United States | $0.232B | 0.00 |
| Omeros (OMER) | United States | $0.228B | 0.00 |
| MacroGenics (MGNX) | United States | $0.207B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.196B | 0.00 |
| High Tide (HITI) | Canada | $0.170B | 70.33 |
| Capricor Therapeutics (CAPR) | United States | $0.167B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 20.62 |
| Brainsway (BWAY) | Israel | $0.140B | 168.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.125B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.124B | 0.00 |
| Veru (VERU) | United States | $0.113B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Jushi Holdings (JUSHF) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 24.20 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.075B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.056B | 3.63 |
| Exagen (XGN) | United States | $0.049B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.036B | 0.00 |
| Bright Green (BGXX) | United States | $0.028B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Agape ATP (ATPC) | $0.008B | 0.00 | |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.47 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |